Moniva, John Bert Lloyd C.
HRN: 11-15-44 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/08/2022
CEFUROXIME 750MG (VIAL)
12/08/2022
12/14/2022
IVT
750
Q8
Neutrophilia
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes